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ABSTRACT   
 
PURPOSE 
The purpose of this study was to evaluate the significance of cerebrovascular CO2 
reactivity (CO2 R) in the course and outcome of inflammatory CNS diseases.  
 
METHODS 
Sixty eight patients with inflammatory CNS diseases and thirty healthy volunteers were 
included in this prospective observational cohort study. The observational period was between 
January 2005 and May 2009.  
CO2 reactivity was measured by Transcranial Doppler ultrasound (TCD) using the 
breath-holding method. We compared patients with normal CO2 R (BHIm ≥ 1.18  = BHIN group) 
with patients who showed impaired CO2 R (BHIm < 1.18 = BHIR group). We also analyzed the 
association of impaired CO2 R with the etiology, severity and outcome of disease.  
 
RESULTS 
 When compared to BHIN group, the patients from BHIR group were older, had a 
heavier consciousness disturbance, experienced more frequent respiratory failure, and 
subsequently had worse outcomes. There were no fatalities among the 28 patients in the BHIN 
group. The comparison of subjects with bacterial and non-bacterial meningitis revealed no 
significant differences. The unfavorable outcome of disease (GOS 1-3) was significantly more 
common in subjects with impaired CO2 reactivity (62.5% vs. 10.7%).  
Logistic regression analysis was performed in order to establish the prognostic value 
of BHIm. The outcome variable was unfavorable outcome (GOS 1-3), while the independent 
variables were age, GCS and BHIm. The age and BHIm showed the strongest influence on 
disease outcome. A decrease of BHIm for each 0,1 unit increased the risk of unfavorable 
outcome for 17%.  
 
CONCLUSIONS 
Our study emphasizes the importance of CO2 reactivity assessment in patients with 
inflammatory CNS diseases.  
 
 
 
 
Key words: CNS infections; bacterial meningitis; CO2 reactivity; Transcranial Doppler (TCD); 
breath-holding 
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INTRODUCTION 
 
Despite advances in the treatment of bacterial meningitis (BM), the overall mortality as 
well as long-term neurological sequelae are still high. This is particularly true with 
pneumococcal meningitis [1-4]. The most common factors associated with poor outcome in 
bacterial meningitis are seizures, advanced age, disturbed consciousness, the presence of 
multiple organ dysfunction, hypotension, APACHE II score > 13, pneumococcal etiology and 
delay in antimicrobial treatment [3-8].  
Cerebrovascular dysregulation represents one of the most deleterious consequences 
of neuroinflammation [9]. The relevance of impaired cerebral blood flow (CBF) 
chemoregulation relies on subsequent hypoperfusion or global ''luxury'' perfusion.  
In addition, although not caused by CO2 reactivity (CO2 R) loss, the severe blood-brain 
barrier disruption frequently occurs in these patients. Therefore, the aggravation of brain 
edema with the use of mannitol infusion due to heavy capillary leak can be expected in such 
patients.  
Beside osmotic diuretics and steroids, the usual treatments for increased intracranial 
pressure include thiopental infusion and hyperventilation [10]. The latter often has limited 
effectiveness if cerebrovascular CO2 reactivity is impaired.  
The alternative and CO2 reactivity-independent symptomatic treatments such as 
therapeutic hypothermia (TH) in such patients hold promise. The effects of mild therapeutic 
hypothermia may target the pathophysiological mechanisms in bacterial meningitis because 
the majority of them are temperature-dependent [11,12].  Even with this knowledge, the CO2 
reactivity (CO2 R) has only been studied in very few patients with BM [13,14].  
Transcranial Doppler ultrasound (TCD) is accepted and considered to be an 
appropriate technique for noninvasive assessment of cerebral arterioles reactivity because the 
changes in mean blood flow velocities (MBFV) correlate with the changes in CBF [15,16]. 
 The aim of this study was to assess the cerebrovascular CO2 reactivity measured by 
TCD using the breath-holding method in patients with inflammatory CNS diseases.  
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MATERIALS AND METHODS 
 
The study was approved by the hospital ethics committee and informed consent was 
obtained from all examinees or their next of kin. 
  
Data collection 
 
 This prospective study was performed between January 2005 and May 2009 at the 
University Hospital for Infectious Diseases in Zagreb. The following parameters were recorded 
in a database: age, gender, physical and neurological signs, mechanical ventilation (MV), 
cerebrospinal fluid (CSF) characteristics, microbiological findings in CSF and blood, mean 
arterial pressure (MAP), Glasgow Coma Scale score (GCS), Glasgow Outcome Scale score 
(GOS) and mean breath-holding index (BHIm). Data was collected during the first 24 hours 
after admission to the Department and within the first five days of illness in all patients.  
 
Patient selection 
 
The patients were eligible for the study if they were 18 years of age or older and had 
inflammatory CNS disease. Patients were excluded if they had brain abscess, subdural 
empyema, nosocomial and shunt meningitis, spinal meningitis or myelitis, stroke, transitory 
ischemic attacks, carotid artery disease, chronic obstructive pulmonary disease (COPD), acute 
respiratory distress syndrome (ARDS), diabetic microangiopathy, septic shock, death not 
related to meningitis, temporal bone ''acoustic window'' absence, or had been treated with 
sodium nitroprusside.  
During the same time period thirty healthy volunteers were studied following written 
informed consent. All volunteers were examined and found to be healthy and without infection. 
The purpose of the control group was to establish the lowest value of the mean breath holding 
index (BHIm) in healthy volunteers. 
 
Definitions 
 
Bacterial meningitis (BM) was diagnosed on the basis of clinical picture (fever, 
headache, neck stiffness and consciousness disturbance with or without seizures and 
neurologic deficits), supportive cerebrospinal fluid findings (pleocytosis, increased protein 
concentration and decreased CSF-blood glucose ratio) and a positive CSF culture; a negative 
CSF culture with a positive CSF PCR assay, a positive blood culture, or a positive Gram stain 
of a CSF sample.  
Non-bacterial inflammatory CNS disease (NBM) was diagnosed on the basis of 
present encephalopathy with at least one of the following: fever, seizures, focal neurological 
findings; pleocytosis with increased protein concentration in the CSF; and a positive CSF or 
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blood culture (fungal meningitis); virus detection by PCR assay in CSF samples; proved 
intrathecal antibody production and electroencephalographic or neuroimaging findings 
consistent with encephalitis or acute disseminated encephalomyelitis (ADEM).   
The patients` mental status was assessed using the Glasgow Coma Scale score 
(GCS). Recorded scores were the lowest during the first 24 hours after admission to the 
hospital. Altered mental status was defined as GCS < 15. The patients’ clinical outcome was 
assessed by using the Glasgow Outcome Scale score (GOS) at the time of discharge from the 
hospital.  
Unfavorable clinical outcomes included death (GOS 1), vegetative state (GOS 2) and 
severe neurological deficit (GOS 3). GOS 5 (mild or no disability) but also GOS 4 (moderate 
disability), were considered favorable outcomes because of extremely detrimental nature of 
CNS infections. 
 According to disease etiology, patients were divided into bacterial (BM) and non-
bacterial (NBM) groups. Thirty healthy volunteers represented the control group. 
Patients were stratified according to CO2 reactivity into “BHIN” (normal CO2 reactivity 
defined with BHIm ≥ 1,18) and “BHIR” (impaired CO2 R defined with BHIm < 1,18 according to 
BHI values in healthy volunteers) groups.  
 
Measurements 
 
TCD measurements of CO2 reactivity were performed during the first 24 hours after 
admission to the hospital by using a Multidop 4 X (DWL, Sipplingen, Germany) with two 2-MHz 
pulsed wave probes 1.7 cm in diameter. The software used was TCD-8 for MDX (Version 8.0, 
Aaslid Rune). Normal basic hemodynamic parameters (mean arterial pressure and heart rate) 
and PaCO2 [35-45 torr (4,67-6,0 kPa)] were confirmed in all examinees before measurements. 
Direct blood pressure monitoring was performed by cannilation of the radial artery. Thus we 
were able to note every change in the arterial pressure which potentially could interfere with 
the measurements.  
The left and right middle cerebral arteries (MCA) were insonated simultaneously 
through the temporal bone windows at a depth of 50-55 mm. The probes were secured to the 
head of the patient with a specially designed spectacle frame that permitted a constant angle 
of insonation. The mean blood flow velocities (MBFV) were continuously recorded during 
normal ventilation and during breath holding.The CO2 reactivity (CO2 R) was assessed using 
the breath-holding method. 
Spontaneously breathing and compliant examinees were asked to hold their breath 
after normal inspiratory breath for 30 seconds or less if it becomes uncomfortable.  
Mechanically ventilated patients were sedated and relaxed before the procedure using 
midazolam and vecuronium bromide, respectively. The administered drugs have no significant 
effect on cerebral vasoreactivity and hemodynamics [17,18]. In that case the patients were 
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disconnected from the ventilator for 30 seconds. Assisted controlled ventilation (ACV) mode 
was used in all mechanically ventilated patients. 
MBFV at the start and at the end of the breath hold period was recorded. The 
procedure was repeated after a five minute rest period and the mean values from both MCAs 
were taken for calculation. The breath-holding index (BHI) was calculated by dividing the 
percentage of MBFV increase during breath holding by the time (in seconds) of apnea. The 
mean breath-holding index (BHIm) was calculated from both MCA (left and right MCA) breath 
holding indexes. 
 
Statistical analysis 
 
Univariate statistics included calculation of the mean value, standard deviation, 
median and interquartiles for continuous variables. Values for categorical variables were 
presented as frequencies. 
Bivariate statistics assessed the differences between compared groups. The Mann-
Whitney's test was used to estimate the difference amongst continuous variables. For 
categorical data the chi-square test and the Fisher’s two-tailed exact test, were used when 
appropriate. All relevant demographic and clinical variables of the patient groups were 
compared.  
The outcome variable was the Glasgow Outcome Scale Score (GOS). The correlation 
between BHIm and the severity of disease was assessed using multivariate tests after bivariate 
analysis. Logistic regression analysis was performed to ascertain the independent predictive 
potential of CO2 reactivity, after adjustment for potential confounding variables. The criteria for 
inclusion of variables in the logistics regression models were based on the evidence of an 
association in the bivariate analysis. P values less than 0.05 were considered statistically 
significant. Data were analyzed using the “SAS 9.1” software (SAS Institute Inc., Cary, NC).  
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RESULTS 
 
Sixty-eight patients and thirty healthy volunteers were included in the study. There 
were no patients requiring vasopressor or inotrope support. Baseline demographics and 
patient characteristics are presented in table 1.  
Thirthy-four patients with bacterial meningitis comprised the BM group. The etiology 
was confirmed in 26 (76.5%) patients. The most common pathogen was Streptococcus 
pneumoniae (12 pts) followed by Neisseria meningitidis (7 pts), Listeria monocytogenes (4 
pts), Klebsiella pneumoniae (1 pt), Enterococcus faecalis (1 pt) and Streptococcus agalactiae 
(1 pt). 
In the NBM group there were 34 patients with non-bacterial meningitis and 
meningoencephalitis. Disease etiology in 12 patients with viral meningoencephalitis (35.2%) 
was not confirmed. The most common pathogen in the remaining patients was Herpes simplex 
virus (6 pts), followed by Tick-borne encephalitis virus (2 pts), Cryptococcus neoformans (2 
pts), influenza A virus (1 pt), Mycobacterium tuberculosis (1 pt), Epstein-Barr virus (1 pt), 
enterovirus (1 pt) and Borrelia burgdorferi (1 pt). Five patients suffered from postinfectious 
meningoencephalitis and two patients had acute disseminated encephalomyelitis (ADEM). 
 The breath-hold period in the control group was 23.3 ± 6.5 seconds (median 23). We 
found no correlation between BHIm and the duration of breath-holding (Spearman R 0.108; 
p=0.623). The possible effect of a too short breath hold to BHI values was thus ruled out.  
Advanced age and higher incidence of respiratory failure that required mechanical 
ventilation were found in the BM group (54 vs. 39 years and 79.4% vs. 50%). 
The most prominent difference between BM and NBM patients was the difference in 
the level of consciousness disturbance (GCS): BM patients had worse scores (GCS 8 vs. 
11.5). Therefore, on-admission GCS score was included in the multivariate model analyzing 
predictivity of BHI for the disease outcome.  
Adjuvant steroid treatment was applied in 56% patients with BM according to the 
current guidelines [2]. Six patients in NBM group received short-term high dose steroids 
because of severe brain edema (4 pts) and acute disseminated encephalomyelitis (2 pts). 
The patients were stratified according to CO2 reactivity and additional analysis was 
made. The normal CO2 reactivity group (“BHIN”) was defined with BHIm≥1.18. The impaired 
CO2 reactivity group (“BHIR”) was defined with BHIm<1.18 according to breath-holding indexes 
in healthy volunteers.  
BHIR group was characterized by advanced age, heavier consciousness disturbance, 
frequent respiratory failure and often unfavorable outcome in contrast to BHIN group (table 2). 
There were no lethal outcomes amongst the 28 patients in BHIN group. 
 In patients with BM and normal CO2 reactivity, we noted a higher incidence of 
mechanical ventilation, advanced age and heavier consciousness disturbance compared with 
patients with NBM and preserved CO2 reactivity (table 2). These findings indicate that in 
patients with BM neither severe consciousness disturbance nor respiratory failure imply 
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necessarily the CO2 reactivity loss. In contrast, unconscious patients with NBM who are 
mechanically ventilated and have normal CO2 reactivity are rare (14.2% vs 50%). 
There was no significant difference in BHI between patients with bacterial meningitis 
that received dexamethasone treatment and those who did not. Normal CO2R was noted in 
36.8% (7/19) patients with steroid treatment compared with 46.6% (7/15) in the non-steroid 
group (p=0.993). 
 The major indicator of disease severity in patients with CNS infections is GCS [3]. 
Because of that, the correlation of BHIm and GCS was analyzed together with other variables 
which may influence BHIm. We found that 80.9% (34/42) of all patients with GCS ≤ 10 had 
impaired CO2 reactivity. In BM and NBM group that was 76% (19/25) and 88.2% (15/17), 
respectively.  
 Univariate regression analysis revealed significant correlation of BHIm with GCS 
(ß=0.098; p<0.001), and BHIm with age (ß= -0.012; p=0.014).  
The unfavorable outcome of disease (GOS 1-3) was noted in 28 patients (28/68; 
41.1%) (table 3). Nine patients died (five patients in BM and four patients in NBM group) and 
the overall mortality was 13.2%. The mortality in pneumococcal meningitis was 33.3% (4/12).  
 The BHIm was almost identical in GOS 1-3 groups regardless of the etiology (BHIm 
median 0.835 in BM versus 0.824 in NBM group).  
 The comparison of BM and NBM groups according to disease outcome and related 
BHIm revealed no significant differences (table 4). Such findings confirmed the BHIm etiology 
independence. However, significant differences in BHIm were noted according to the GOS 
(Figure 1).  
The BHIm in the favorable group (GOS 4-5) was significantly higher (1.285 vs. 0.835) than in 
the unfavorable group (GOS 1-3) (table 3). The unfavorable outcome of disease (GOS 1-3) 
was significantly more frequent in patients with impaired CO2 reactivity (62.5 vs. 10.7%) (table 
2). 
Logistic regression analysis was performed in order to establish the prognostic value 
of BHIm. The outcome variable was unfavorable outcome (GOS 1-3), while the independent 
variables were age, GCS and BHIm. The appropriateness of the fitted model and its predictive 
utility was confirmed. Patient age and BHIm showed the strongest influence on disease 
outcome. A decrease of BHIm for each 0.1 unit increases the risk of unfavorable outcome by 
17%. An increase of age for one year increases the risk of unfavorable outcome by 6% (table 
5). These results indicate that BHIm changes might have a better predictive value than GCS. 
Receiver operating characteristic (ROC) curve showed that BHIm has better explanatory value 
than GCS (AUC 0.785 vs. 0.745).  
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DISCUSSION 
 
This prospective study assessed cerebrovascular reactivity (CO2R) by TCD using the 
breath-holding method in patients with inflammatory CNS diseases. We found that impaired 
CO2R is independently associated with the severity and outcome of disease.  
The etiology of CNS infection did not show a significant association with 
chemoregulation loss. However, the etiology was associated with the severity of disease and 
mechanical ventilation requirement. In patients with BM we found a higher incidence of 
respiratory failure, advanced age and heavier consciousness disturbance. This finding, 
however, doesn’t imply obligatory chemoregulation loss in these patients. Their grave 
condition can be explained with reasons outside the CNS such as multiple organ 
dysfunction/failure due to severe systemic inflammatory reaction and other co-morbidities in 
older patients. In addition, there were no lethal outcomes in mechanically ventilated patients 
with normal CO2R regardless of etiology. The mortality rate in mechanically ventilated patients 
with impaired CO2R was similar in both groups (25% vs. 26.6%).  
 In contrast to previous reports we found no significant influence of adjuvant 
dexamethasone treatment on CBF chemoregulation recovery [19].  
 The analysis of BHI according to disease outcome ascertained the association of 
impaired CO2R with unfavorable outcome (GOS 1-3).  According to literature review, the 
impaired CBF chemoregulation is almost exclusively confined to bacterial meningitis [9]. That 
is probably because of particular interest in pneumococcal meningitis patophysiology and the 
great number of experimental studies [20-24]. The lipid peroxidation and effects of matrix 
metalloproteinases with consequent endothelial dysfunction seems a plausible explanation.  
According to our results, the most severe CNS infections result with CO2R impairment or 
complete CO2R loss which was proved to be etiology-independent. The possible mechanisms 
which could explain the chemoregulation loss in viral and other non-bacterial CNS infections 
are not known. Intracranial hypertension alone, regardless of cause, can not explain impaired 
CO2R. For example, most patients with extreme intracranial hypertension due to cerebral 
abscess or tumors have normal CO2R and the use of hyperventilation as well as mannitol 
infusion results in obvious short-term improvement. A similar response could be seen in 
patients with bacterial meningitis and preserved CO2R.  
 We chose the breath holding method because it proved to be nonaggressive, well 
tolerated, real-time, reliable and reproducible [15,25]. The lowest BHIm in our healthy 
volunteers was similar to previously reported BHIm by Zavoreo and Demarin (1.18 vs 1.03) 
[25]. 
 Other methods such as inhalation of 5% CO2 or acetazolamide injection strongly 
stimulate vasodilatation of cerebral arterioles [15,26]. Because they also carry the risk of 
cerebral hyperemia and intracranial hypertension aggravation, these methods are not 
appropriate for evaluation of cerebral vasoreactivity in patients with severe acute CNS 
infections. A more advanced techniques to assess the small and medium sized vessel 
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reactivity such as ASL-MRI (arterial-spin labeled magnetic resonance imaging) and BOLD 
(blood oxygenation level dependent) imaging are usually unavailable.   
A major disadvantage of breath holding method is the necessity for patients’ full 
cooperation if they are not mechanically ventilated. Besides disease severity, the inability of 
compliance in a proportion of patients is the reason for a relatively high proportion of 
mechanically ventilated patients in our study (64.7%; 44/68). That is the recognized limitation 
of our study. The second limitation of the study is a relatively small patient population. This 
occurred because of strict exclusion criteria and may have resulted in selection bias.  
Despite the limitations of our study, our results confirmed the importance of CO2 
reactivity assessment in patients with CNS infections. CO2R showed good correlation with the 
severity and outcome of bacterial as well as non-bacterial meningitis. However, the most 
important value of CO2R is the capability to define patients with chemoregulation loss 
immediately upon admission to the hospital. It should be stressed that it is not possible to 
distinguish these patients by clinical examination or with CT brain scan. The effects of 
conventional symptomatic treatment (osmotic diuresis, thiopental, hyperventilation) are greatly 
dependent (or associated with) on cerebral arterioles vasoreactivity [27]. Patients with 
impaired CO2R are candidates for therapeutic hypothermia (TH). This life-saving procedure 
should be started as soon as possible because conventional symptomatic treatment failure 
and poor outcome of disease in these patients should be anticipated.  
 Based on the results of this study, we made an internal guideline for TH in patients 
with severe CNS infections. The major criterion for therapeutic hypothermia is impaired CO2 
reactivity assessed by TCD.  In patients without temporal acoustic window, minor criteria [optic 
nerve sheath diameter ≥ 6.0, GCS ≤ 8 and SjO2 (jugular bulb venous saturation) < 55% or 
>75%] are required.  
Therapeutic hypothermia during CNS infections may assist with the reduction in 
cerebral metabolism, cerebral blood volume (CBV), lowering of the intracranial pressure and 
suppression of the inflammatory host response allowing maintenance of adequate cerebral 
perfusion pressure. According to our experience, the recovery of CO2 reactivity cannot be 
expected before the fourth day of treatment. We recommend the use of TH as soon as 
possible and at least during the first three days after presentation. The first results of that 
therapeutic concept in patients with BM are very promising [28]. Therapeutic hypothermia 
halved the overall mortality in patients with BM and significantly decreased the mortality rates 
in patients with viral meningoencephalitis at our hospital during the last two years (12% vs. 
24% and 9% vs. 20%, respectively - unpublished data).    
 Our study emphasizes the importance of CO2 reactivity assessment in patients with 
CNS infections regardless of etiology. A great predictive value as well as reliable stratification 
criteria in treatment strategy decision makes this method a very promising tool.  
 
     
 11
ACKNOWLEDGEMENTS 
We thank Petar Mamula MD, Joel  Friedlander DO, MBe,  Mrs. Arijana Pavelić and 
Mrs. Marija Fijucek for their help in the preparation of the manuscript.  
 
     
 12
REFERENCES 
 
1. Lu CH, Huang CR, Chang WN, et al. (2002) Community-acquired bacterial meningitis in  
adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. 
Clin Neurol Neurosurg 104(4):352-358 
 
2. Cohen J (2003) Management of bacterial meningitis in adults: Algorithm from the British 
Infection Society represents current standard of care. British Medical Journal 326(7397):996-
997 
 
3. Lepur D, Baršić B (2007) Community-acquired bacterial meningitis in adults: antibiotic timing 
in disease course and outcome. Infection 35(4):225-231 
 
4. Van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM (2006) Community-acquired bacterial 
meningitis  in adults. N Engl J Med 354:44-53 
 
5. Flores-Cordero JM, Amaya-Villar R, Rincon Ferrari MD, et al. (2003) Acute community-
acquired bacterial meningitis in adults admitted to the intensive care unit: clinical 
manifestations, management and prognostic factors. Intensive Care Med 29:1967-1973 
 
6. Durand ML, Calderwood SB, Weber DJ, et al. (1993) Acute bacterial meningitis in adults. N 
Engl J Med 328:21-28 
 
7. Aronin S, Peduzzi P, Quagliarello V (1998) Community-acquired bacterial meningitis: Risk 
stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern 
Med129:862-869 
 
8. Van de Beak D, de Gins J, Spaniard L, Wiesel M, Riesman JB, Vermilion M (2004) Clinical  
features  and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849-
1859 
 
9. Scheld WM, Koedel U, Nathan B, Pfister HW (2002)  Pathophysiology of bacterial 
meningitis: mechanism(s) of neuronal injury. J Infect Dis 186 Suppl 2:S225-233 
 
10. Grande PO, Asgeirsson B, Nordstrom CH (2002) Volume-targeted therapy of increased 
intracranial pressure:the Lund concept unifies surgical and non-surgical treatments. Acta 
Anaesthesiol Scand 46:929-941 
 
11. Polderman KH (2009) Mechanism of action, physiological effects, and complications of 
hypothermia. Crit Care Med 37(7) Suppl:186-202 
 
12. Koedel U, Scheld WM, Pfister HW (2002) Pathogenesis and pathophysiology of 
pneumococcal meningitis. Lancet Infect Dis 2(12):721-736 
 
13. Moller K, Strauss GI, Thomsen G, et al. (2002) Cerebral blood flow, oxidative metabolism 
and cerebrovascular carbon dioxide reactivity in patients with acute bacterial meningitis. Acta 
Anaesthesiol Scand 46:567-578 
 
14. Ashwal S, Stringer W, Tomasi L, Schneider S, Thompson J, Perkin R (1990) Cerebral 
blood flow and carbon dioxide reactivity in children with bacterial meningitis. J Pediatr; 
117(4):523-530 
 
15. Markus HS, Harrison MJG (1992) Estimation of cerebrovascular reactivity using 
transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus. Stroke 
23:668-673 
 
16. White H, Venkatesh B (2006) Applications of transcranial Doppler in the ICU: a review. 
Intensive Care Med 32(7):981-94 
 
     
 13
 
 
17.Strebel S, Kaufmann M, Guardiola PM, Schaefer HG (1994) Cerebral vasomotor 
responsiveness to carbon dioxide is preserved during propofol and midazolam anesthesia in 
humans. Anesth Analg 78(5): 884-888 
 
18. Nitschmann P, Oberkogler W, Hertsig M, Schwarz S (1994) Comparison of haemodynamic 
effects of rocuronium bromide with those of vecuronium in patients undergoing CABG surgery. 
Eur J Anaesthesiol Suppl 9:113-115 
 
19. Mertineit C, Samlalsingh-Parker J, Glibetic M, Ricard G, Noya FJ, Aranda JV (2000) Nitric 
oxide, prostaglandins, and impaired cerebral blood flow autoregulation in group B 
streptococcal neonatal meningitis. Can J Physiol Pharmacol 78(3):217-227 
 
20.Hashimoto K, Houdou S, Ando Y, Okasora T (1989) Usefulness of ultrasonography and 
transcranial Doppler flowmetry in evaluation of infantile bacterial meningitis. No To Hattatsu 
21(5):475-480 
 
21. Fassbender K, Ries S, Schminke U, Schneider S, Hennerici M (1996)  Inflammatory 
cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal 
cerebral arteries, J Neurol Neurosurg Psychiatry 61(1):57-61 
 
22. Muller M, Merkelbach S, Huss GP, Schimrigk K (1995) Clinical relevance and frequency of 
transient stenoses of the middle and anterior cerebral arteries in bacterial meningitis. Stroke 
26(8):1399-1403 
 
23. Haring HP, Rotzer HK, Reindl H, Berek K, Kampfl A, Pfausler B, Schmutzhard E (1993) 
Time course of cerebral blood flow velocity in central nervous system infections. A transcranial 
Doppler sonography study. Arch Neurol 50(1):98-101 
 
24. Muller M, Merkelbach S, Schimrigk K (1996) Cerebral hemodynamics in the posterior 
circulation of patients with bacterial meningitis. Acta Neurol Scand 93(6):443-449 
 
25. Zavoreo I, Demarin V (2004) Breath holding index in the evaluation of cerebral 
vasoreactivity. Acta Clin Croat 43:15-19 
 
26. Cigada M, Marzorati S, Tredici S, Iapichino G (2000) Cerebral CO2 vasoreactivity 
evaluation by transcranial Doppler ultrasound technique: a standardized methodology. Intensiv 
Care Med 26:729-732 
 
27. Messeter K, Nordstrom CH, Sundbarg G, Algotsson L, Ryding E (1986) Cerebral 
hemodynamics in patients with acute severe head trauma. J Neurosurg 64:231-237 
 
28. Lepur D, Kutleša M, Baršić B (2010) Induced hypothermia in adult community-acquired 
bacterial meningitis – more than just a possibility? J Infect.  doi:10.1016/j.jinf.2010.10.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 14
 
TABLES 
 
 
 
 
Table 1   Baseline demographic data and characteristics of examinees 
 
 
 
Legend: 
 
a
 BHIm median:  control group vs all patients 
b
 BHIm median:  BM vs NBM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Control 
group 
(N=30) 
Bacterial 
meningitis (BM) 
(N=34) 
Non-bacterial 
meningitis (NBM)  
(N=34) 
 
p-value 
Age (years) 
        median 
        interquartiles 
 
38 
26-55 
 
54 
44-61 
 
39 
25-52 
 
0.018
 
 
Gender 
        male 
        female 
 
15 (50%) 
15 (50%) 
 
26 (76.5%) 
  8 (23.5%) 
 
20 (59%) 
14 (41%) 
 
0.081
 
 
GCS 
         median 
         interquartiles 
 
N/A  
 
8 
6-12 
 
11,5 
6-15 
 
<0.001
 
 
Neurological deficit 
 
N/A 11 (32.3%) 12 (35.2%) 1.000
 
Steroid treatment 
 
N/A 19 (56%) 6 (17.6%) 0.002
 
Mannitol infusion 
 
N/A 25 (73.5%) 20 (59%) 0.305
 
Respiratory failure 
requiring mechanical 
ventilation 
 
 
N/A 
 
27 (79.4%) 
 
17 (50%) 
 
0.022
 
 
Mean breath-holding 
index (BHIm)                                           
            median 
            interquartiles 
            range 
 
 
1.878 
1.513-2.185 
1.180-2.996 
 
 
 
1.042 
0.675-1.377 
0.113-3.02 
 
 
 
1.115 
0.736-1.795 
0.214-2.857 
 
<0.001
a
 
   0.389
b 
 
Glagow Outcome Scale 
Score (GOS) 
 
              GOS 1 
              GOS 2 
              GOS 3 
              GOS 4 
              GOS 5 
 
 
 
 
 
 
N/A 
 
 
 
5 (14.7%) 
2 (5.9%) 
9 (26.4%) 
4 (11.9%) 
14 (41.1%) 
 
 
 
4 (11.8%) 
0 
8 (23.5%) 
4 (11.8%) 
18 (52.9%) 
 
 
 
 
 
0.729 
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Table 2  Characteristics and the outcome of patients according to the CO2 reactivity  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: 
 
†
 BHIN = BHI ≥ 1.18 (normal CO2 reactivity) 
‡
 BHIR  = BHI < 1.18 (reduced CO2 reactivity) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
BHIN
†
 
 
BHIR
6
 
 
p-value 
 
All patients (N=68) 
                 N (%) 
                 age – years (median) 
                 GCS (median) 
                 mechanical ventilation  N (%) 
                 GOS 1-3  N (%) 
                 mortality  N (%) 
                   
 
 
28 (41.2) 
37 
15 
9 (32.1) 
3 (10.7) 
0  
 
 
40 (58.8) 
52 
7.5 
35 (87.5) 
25 (62.5) 
9 (22.5) 
 
 
N/A 
0.002
 
<0.001
 
<0.001 
<0.001 
0.008 
 
Bacterial meningitis (N=34) 
                 N (%) 
                  age – years (median) 
                  GCS (median) 
                  mechanical ventilation  N (%) 
                  GOS 1-3  N (%) 
                  mortality  N (%) 
                   
 
 
14 (41.2) 
44.5 
13.5 
7 (50) 
2 (14.2) 
0 
 
 
20 (58.8) 
59 
7.5 
20 (100) 
14 (70) 
5 (25) 
 
 
N/A 
<0.001
 
0.004
 
<0.001 
0.004
 
0.062 
 
Non-bacterial meningitis (N=34) 
                  N (%) 
                  age – years (median) 
                  GCS (median) 
                  mechanical ventilation  N (%) 
                  GOS 1-3  N (%) 
                  mortality  N (%) 
 
 
14 (41.2) 
29.5 
15 
2 (14.2) 
1 (7.1) 
0 
 
 
20 (58.8) 
43.5 
7.5 
15 (75) 
11(55) 
4 (20) 
 
 
N/A 
0.306
 
<0.001
 
0.001 
0.009
 
0.126 
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Table 3  Characteristics of the outcome groups   
 
 
 GOS 1-3 
(unfavorable 
outcome) 
N=28 
GOS 4-5 
(favorable  
outcome) 
N=40 
 
p-value 
Age (years) 
         median                  
         interquartiles 
 
55 
44-65 
 
39 
22-52 
 
<0.001 
GCS 
         median                  
         interquartiles 
 
7.5 
4-10 
 
13.5 
7.5-15 
 
<0.001 
mechanical ventilation 
             N (%) 
 
26 (92.8%) 
 
18 (45%) 
 
<0.001
 
BHIm  
      median                  
      interquartiles 
 
0.835 
0.551-1.044 
 
1.285 
0.902-1.934 
 
<0.001 
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Table 5    Variables associated with unfavorable outcome – logistic regression analysis 
 
Odds Ratio Estimates 
Variable OR 95% Wald 
Confidence Limits 
Age 1.063 1.017 1.110 
GCS 1.089 0.914 1.298 
BHIm 4.922 1.161 20.875 
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FIGURES 
 
 
 
 
 
Figure 1.  BHIm according to disease outcome (Glasgow outcome scale score) 
 
